NKGN
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- NKGen Biotech to present on use of Troculeucel for neurodegenerative diseases at 3rd China Great Bay Cell and Gene Therapy ForumSep 18, 2025
- NKGen receives FDA expanded access protocol authorization for landmark treatment of several neurodegenerative diseasesJul 21, 2025
- NKGen Biotech administers first dose of Troculeucel to Alzheimer's patient who continued cognitive decline on prior amyloid therapyJul 11, 2025
- NKGen Biotech expands Phase 1/2a Troculeucel Alzheimer's trial internationally with new clinical sites in Canada and FloridaJun 23, 2025